Baxter (NYSE: BAX) reported Q3 EPS of $0.68, $0.01 better than the analyst estimate of $0.67. Revenue for the quarter came in at $3.71 billion versus the consensus estimate of $3.7 billion.

GUIDANCE:

Baxter sees FY2023 EPS of $2.57-$2.60, versus the consensus of $2.57.

For earnings history and earnings-related data on Baxter (BAX) click here.